Hans J. Moebius
Impact in
- Biological Psychiatry top 10%
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Alzheimer's disease research and treatments 6
-
- Pharmacological Receptor Mechanisms and Effects 2
- Nicotinic Acetylcholine Receptors Study 2
- Co-authors
- Gordon Wilcock (2 shared papers)Luc Bracoud (1 shared paper)Serge Gauthier (1 shared paper)Giovanni B. Frisoni (1 shared paper)Kohkan Shamsi (1 shared paper)Claude M. Wischik (1 shared paper)Lon S. Schneider (1 shared paper)Damon Wischik (1 shared paper)
- Journals
- Alzheimer s & Dementia (4 papers)Neurotherapeutics (2 papers)European Neuropsychopharmacology (2 papers)International Psychogeriatrics (1 paper)Journal of Alzheimer s Disease (1 paper)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Hans J. Moebius
18 papers receiving 635 citations
Hans J. Moebius's Hit Papers
Peers
Comparison fields: 5 of 78
- Biological Psychiatry 53
- Neurology 110
- Physiology 255
- Pharmacology 158
- Sensory Systems 40
Countries citing papers authored by Hans J. Moebius
This map shows the geographic impact of Hans J. Moebius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans J. Moebius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans J. Moebius more than expected).
Fields of papers citing papers by Hans J. Moebius
This network shows the impact of papers produced by Hans J. Moebius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans J. Moebius. The network helps show where Hans J. Moebius may publish in the future.
Co-authors
The 25 scholars most cited alongside Hans J. Moebius, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial Hit paper breakdown → | 2016 | 326 |
| 2 | 2015 | 122 | |
| 3 | 2014 | 74 | |
| 4 | 2011 | 40 | |
| 5 | 2022 | 23 | |
| 6 | 2000 | 15 | |
| 7 | 2022 | 13 | |
| 8 | 2020 | 7 | |
| 9 | 2023 | 6 | |
| 10 | 2024 | 5 | |
| 11 | 2013 | 5 | |
| 12 | 2012 | 4 | |
| 13 | 2024 | 4 | |
| 14 | 2003 | 4 | |
| 15 | 2022 | 3 | |
| 16 | 2024 | 3 | |
| 17 | 2023 | 3 | |
| 18 | 2023 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2025 | 0 |
About Hans J. Moebius
Hans J. Moebius is a scholar working on Physiology, Molecular Biology, Pharmacology, Psychiatry and Mental health and Developmental Neuroscience, having authored 20 papers that have together received 658 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (6 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), Dementia and Cognitive Impairment Research (3 papers), Neurogenesis and neuroplasticity mechanisms (2 papers), Liver physiology and pathology (2 papers), Pharmacological Receptor Mechanisms and Effects (2 papers), Nicotinic Acetylcholine Receptors Study (2 papers) and Pharmaceutical Practices and Patient Outcomes (1 paper). The work is most often cited by research in Biological Psychiatry (53 citations), Neurology (110 citations), Physiology (255 citations), Pharmacology (158 citations) and Sensory Systems (40 citations). Hans J. Moebius has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Gordon Wilcock, Luc Bracoud, Serge Gauthier, Giovanni B. Frisoni, Kohkan Shamsi, Claude M. Wischik, Lon S. Schneider, Damon Wischik, John M. D. Storey and Karin A. Kook. Their work appears in journals such as Alzheimer s & Dementia, Neurotherapeutics, European Neuropsychopharmacology, International Psychogeriatrics and Journal of Alzheimer s Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.